Next Article in Journal
Voting with Your Feet: The Impact of Urban Public Health Service Accessibility on the Permanent Migration Intentions of Rural Migrants in China
Previous Article in Journal
Development and Validation of a Meta-Instrument for Nursing Assessment in Adult Hospitalization Units (VALENF Instrument) (Part I)
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Exposure to Misinformation, Risk Perception, and Confidence towards the Government as Factors Influencing Negative Attitudes towards COVID-19 Vaccination in Malaysia

by
Emma Mohamad
1,2,
Jen Sern Tham
3,
Siti Zaiton Mohd Ajis
1,2,
Mohammad Rezal Hamzah
4,
Suffian Hadi Ayub
5,
Andi Muhammad Tri Sakti
1,2,6 and
Arina Anis Azlan
1,2,*
1
Centre for Research in Media and Communication, Faculty of Social Sciences and Humanities, Universiti Kebangsaan Malaysia, Bangi 43600, Selangor, Malaysia
2
UKM × UNICEF Communication for Development Centre in Health, Faculty of Social Sciences and Humanities, Universiti Kebangsaan Malaysia, Bangi 43600, Selangor, Malaysia
3
Department of Communication, Faculty of Modern Languages and Communication, Universiti Putra Malaysia, Seri Kembangan 43400, Selangor, Malaysia
4
Department of Communication, Faculty of Business and Communication, Universiti Malaysia Perlis, Kangar 01000, Perlis, Malaysia
5
Faculty of Communication and Media Studies, Universiti Teknologi MARA, Shah Alam 40450, Selangor, Malaysia
6
Faculty of Communication Science, Mercu Buana University, Jakarta 11650, Indonesia
*
Author to whom correspondence should be addressed.
Int. J. Environ. Res. Public Health 2022, 19(22), 14623; https://doi.org/10.3390/ijerph192214623
Submission received: 30 September 2022 / Revised: 3 November 2022 / Accepted: 4 November 2022 / Published: 8 November 2022
(This article belongs to the Section Health Communication and Informatics)

Abstract

:
Introduction: This study explored exposure to misinformation, COVID-19 risk perception, and confidence towards the government as predictors of negative attitudes toward the COVID-19 vaccine. Methods: A cross-sectional survey was carried out from 30 June to 30 August 2021 involving 775 respondents. The survey instrument for the questionnaire was an adaptation from various different studies consisting of five main variables: (1) misinformation about vaccination; (2) risk perception toward COVID-19; (3) attitudes toward the vaccination programme; (4) intention to get vaccinated; and (5) public confidence in the government in executing the vaccination programme. Results: The results of this study indicate that higher exposure to misinformation led to higher levels of negative attitudes toward the COVID-19 vaccine. When the perceived risk of COVID-19 infection was high, mistrust of vaccine benefits was low but there were also higher worries about the future effects of the vaccine. Confidence in the government was associated with lower negative attitudes toward the COVID-19 vaccine. Conclusion: The results of this study may help develop an understanding of negative attitudes toward vaccinations in Malaysia and its contributing factors.

1. Introduction

COVID-19 vaccinations have become crucial in supplementing individual preventive actions to combat the pandemic, and vaccination coverage is critical for maintaining efficient public health measures. Governments worldwide have made significant efforts to implement successful procurement and vaccination programmes for individuals since the availability of COVID-19 vaccines [1]. The severity of the COVID-19 pandemic on populations worldwide will be reduced significantly only if the worldwide vaccination deployment is successful. On the other hand, a vaccination programme is not without difficulties, particularly on a global scale. While the goal is to make the COVID-19 vaccine available and accessible to everyone, persuading people to vaccinate themselves is a different issue.
Nonetheless, due to the rapid process of vaccine development, various questions concerning vaccine acceptability and safety emerged as community concerns potentially influencing attitudes and behaviours toward vaccine hesitancy [2]. An earlier study proved how public negative attitudes toward the COVID-19 vaccine resulted in prominent resistance toward vaccination in the first phase of its introduction, even when the health authorities made it compulsory [3]. Among negative attitudes surrounding COVID-19 vaccine hesitancy were concerns about vaccine safety [4], worries about potential unforeseen side effects, a high level of mistrust of vaccine benefits [5], concerns of commercial profiteering [6], and preference towards natural immunity compared to the vaccine [7]. Therefore, to convince the public to agree to be vaccinated, trust must be built; information about the development of these vaccines must be made public so that people are aware and informed.
The significant growth of health information sources online has made it challenging for health authorities to ensure that accurate information reaches the public. Studies have documented the prevalence of misinformation on health-related issues such as vaccination, pandemic, non-communicable diseases, and medical treatment [8] and its role in diverting individuals from performing correct health behaviour, including preventive behaviour during the COVID-19 pandemic. Several factors, such as poor information infrastructure, lack of proper knowledge-sharing culture, and resistance to technology adaptation, remain the main challenges in dealing with misinformation [9]. Previous studies have shown that exposure to misinformation has led people to perform misguided COVID-19 preventive behaviours while discouraging them from performing the recommended ones [10]. Exposure to misinformation has also increased religious misinformation beliefs and conspiracy beliefs [11] and negatively impacted individuals’ mental health [12].
The prevalence of misinformation related to COVID-19 is high on social media and broadly delivered via online messaging services, making it an added challenge for the government to end the pandemic. Moreover, inaccurate beliefs can also be caused by the government’s inability to clarify and provide trusted information to counter the misinformation [13], which often leads to mistrust toward the government. Studies have suggested that clear messages and knowledge dissemination were positively associated with trust in the government when introducing COVID-19-preventive behaviours [14]. In regard to vaccination intake, several studies also revealed how the element of mistrust—mistrust toward health authorities and healthcare workers [15], mistrust towards biomedical science [16], and mistrust in medical information while believing conspiracy theories [17]—is significantly associated with vaccine hesitancy.
Another factor associated with the decision to take the vaccine is risk perception. A previous study has shown that public intention to be vaccinated is influenced by their perceived likelihood of being infected and the potential adverse effect of contracting COVID-19 [18,19]. In turn, risk perception is influenced by factors such as incorrect beliefs spread on social media (e.g., COVID-19 is no more dangerous than influenza, and there is no need to wear a mask) [20], experience of COVID-19, mass media exposure, knowledge about COVID-19, and perceived mortality. Populations of low-to-middle-income countries experienced higher mortality rates due to COVID-19 [21] yet showed more willingness to take the COVID-19 vaccines as compared to populations of high-income countries [22].
In Malaysia, there has been a discrepancy between public confidence in national and state governments in handling vaccination programmes. It was reported that most Malaysians trust the federal government’s ability to curb COVID-19 through its vaccination programme [23], which resulted in a high vaccination rate. However, a study in Sabah revealed confidence and convenience as factors associated with vaccine hesitancy among Sabah populations, particularly among the self-employed and unemployed [24]. The study also showed religious belief (being a Muslim) as one of the demographic factors associated with vaccine hesitancy. Corroborating the above findings, Ruhi et al., through their study comparing vaccine hesitancy among West and East Malaysian populations, noted that religious restrictions make vaccine hesitancy more problematic in East Malaysia as compared to in West Malaysia [25]. The lack of public confidence in the government and community disagreement over the religious permissibility of vaccines in certain parts of this country has proven the lack of proper communication messaging and a system to counter the negative public perception towards vaccination. Even so, the opportunity to correct public misperception remains open as a study reported that many populations exposed to vaccine misinformation still want to acquire additional vaccine-related information to overcome their vaccine hesitation [26].
While many studies have examined the role of negative attitudes toward vaccine hesitancy [3,4,27], the present study aims to explore factors that influence an individual’s negative attitudes toward vaccination. It is hypothesised that exposure to misinformation, COVID-19 risk perception, and confidence towards the government are predictors to negative attitudes toward the COVID-19 vaccine. This study employed a cross-sectional survey that was carried out from 30 June to 30 August 2021 during the second phase of the COVID-19 lockdowns in Malaysia and also when the COVID-19 vaccinations were initially being made available to the public. The results of this study may help in developing an understanding of negative attitudes toward vaccinations in Malaysia and their contributing factors.

2. Materials and Methods

2.1. Study Design and Setting

This cross-sectional investigation was conducted from 30 June to 30 August 2021 during the first phase of the National Recovery Plan period in Malaysia. This study was funded by Universiti Kebangsaan Malaysia (UKM) through a matching grant collaboration with UNICEF in order to investigate exposure to misinformation, risk perception, and public confidence in the government on the COVID-19 vaccination programme. The study received ethical approval from the UKM Ethics Committee which covered the aspects of protocol, procedures, the information sheet, and the consent statement (JEP-2020-276). A total of 775 respondents were involved in the study, representing the Malaysian population with a ±5% margin of error and a confidence level of 95% [28,29].

2.2. Data Collection

The data were collected online using the Survey Monkey platform, and the invitation to participate in this study was voluntary. To participate, respondents were required to read the information sheet and give consent by clicking the ‘Continue’ button prior to answering the self-administered questionnaire. Members of the Malaysian public who participated in the study were above the age of 18 and were currently residing in the country. Several strategies were employed to reach the targeted number of respondents despite the MCO. Overall, the dissemination of the survey utilised various social media platforms (WhatsApp, Facebook, Twitter, and Instagram). Facebook and WhatsApp were most effective as the most popular social media platforms in Malaysia [30]. The researchers also reached out to numerous networks through emails and personal outreach. The message to the survey link and a general description of the survey and questionnaire was prepared in English and the Malay language, considering the multi-ethnic demographics in Malaysia.

2.3. Survey Questionnaire

The survey instrument for the questionnaire was an adaptation from various different studies. The questionnaire consisted of five main variables: (1) misinformation about vaccination; (2) risk perception toward COVID-19; (3) attitudes toward the vaccination programme; (4) intention to get vaccinated; and (5) public confidence in the government in executing the vaccination programme. Since the questionnaire was bilingual (English and Malay language), the study used a backwards-translation approach to translate the items between both languages. This was done to ensure linguistic and conceptual equivalence [31]. For validation of language constructs, bilingual arbiters were sought to consult and rectify any discrepancies on both versions.
To measure exposure to misinformation on vaccination, 10 items were adapted from previous research [32] using a Likert scale (1—‘Not at all’ to 4—‘Very frequently’). In order to measure risk perception toward vaccination, the respondents were asked to answer four questions adapted from previous studies [33,34,35]. The answer scale utilised was from 1—‘Not at all’ to 6—‘Completely’. Negative attitudes toward the vaccination programme were measured through four sub-domains: (i) mistrust of vaccine benefits (3 items); (ii) worries about unforeseen future effects (3 items); (iii) concerns about commercial profiteering (3 items); and (iv) preference for natural immunity (3 items). The Likert scale for these items ranged from 1—’ Strongly disagree’ to 6—‘Strongly agree’. Items for attitudes toward vaccination were adapted from past research [5,36]. To measure the intention of the Malaysian public to get vaccinated, 1 item was adapted from previous research [37] with a dichotomous answer scale (Yes or No). Finally, the measurement of public confidence was adapted from previous research [5] with 2 items. The Likert scale employed for both items was 1—‘No confidence’ to 6—‘Very high confidence’. Scores for the items in each variable were averaged to obtain total scores.

2.4. Statistical Analysis

For this study, the data collected were analysed using the Statistical Package for the Social Sciences (SPSS), version 26. Descriptive analysis focused on frequencies and percentages for demographics; for inferential tests, the statistical significance level was set at p < 0.05. Internal consistency of the knowledge measures was tested using a reliability test, where the Cronbach’s alpha coefficient aided in determining the reliability of the variables. The results showed that the Cronbach’s alpha for misinformation (10 items) was 0.842. For risk perception (4 items), the Cronbach’s alpha was 0.676. For the four domains of attitudes toward the vaccination programme, (i) for mistrust of vaccine benefit (3 items), the Cronbach’s alpha was 0.878; (ii) for worries about unforeseen future effects (3 items), the Cronbach’s alpha was 0.769; (iii) for concerns about commercial profiteering (3 items), the Cronbach’s alpha was 0.812; and (iv) for preference for natural immunity (3 items), the Cronbach’s alpha was 0.786. The Cronbach’s alpha for public confidence was 0.833. This adds credence to the results as stated by Griethuijsen, Cronbach’s alpha values above 0.6 were considered adequate and reliable [38]. A hierarchical regression procedure was conducted to determine the relationships between selected demographics, exposure to misinformation, risk perception toward COVID-19, public confidence, and attitudes toward the vaccination programme.

3. Results

3.1. Descriptive Statistics

The main characteristics of the study population are reported in Table 1. The pool of respondents was 69.2% female and 30.8% male, with an average age of 33.71 years (SD = 10.71). Most of the respondents were ethnic Malay (67.5%), from Selangor and Kuala Lumpur (47.5%), lived in urban areas (64.9%), and worked in the private sectors (47%). Moreover, 54% of the respondents had income less than MYR 4360 per month or no income at all. The majority of the respondents reported good health status (84.6%), and 81.3% reported having no diseases at the time of the survey.
Table 2 presents the respondents’ primary sources of COVID-19 information. The most common information sources were government organisations, newspapers or online newspapers, and doctors or healthcare providers. Conversely, alternative medicine practitioners were the source least referred to by respondents when seeking COVID-19 information.
As shown in Table 3, respondents utilised online, social, and mainstream media to access information about COVID-19 vaccines. The majority of respondents preferred to use online news portals, Facebook, and television. Few respondents used radio and YouTube for news related to COVID-19 vaccines.

3.2. Exposure to Misinformation on COVID-19 Vaccination

Overall, the surveyed respondents were exposed to at least one kind of misinformation about COVID-19 vaccines (mean 1.81). Almost 60% of respondents reported that they were not exposed to misinformation related to COVID-19 vaccines affecting human DNA, COVID-19 vaccines containing pig fat (60.9%), and that COVID-19 vaccines can cause infertility in women (64%). The survey indicated that respondents were exposed (rarely, occasionally, and very frequently) to information about the COVID-19 vaccine causing severe side effects such as allergic reactions (82.5%); that COVID-19 vaccines cause serious side effects such as allergic reactions (62.1%); that a nurse fainted after she received the COVID-19 vaccine (58%); that COVID-19 vaccines contain live viruses that can make people sick with COVID-19 (46.7%); that once a person receives the COVID-19 vaccine, they will not have to wear a mask or practice social-distancing (42.4%); that those who have recovered from COVID-19 do not need to get vaccinated (40.9%); that COVID-19 vaccines affect human DNA (40.2%); that vaccines for COVID-19 have a microchip that can track the location of the patient (40%); that COVID-19 vaccines contain pig fat (39.2%); and that the COVID-19 vaccine can cause infertility in women (36%). This is presented in Table 4.

3.3. Risk Perception about COVID-19

The study found that 88% of respondents believed that COVID-19 is a problem that is important to them, and 80% indicated that they were worried about being infected with COVID-19 in the future (Table 5). However, only one-third of respondents (38.7%) believed they were likely to be infected with COVID-19 and felt at risk of COVID-19 infection (39.6%).

3.4. Attitudes toward the Vaccination Programme

A total of 82.2% of respondents agreed that they felt safe after being vaccinated. The majority of respondents (72.5% and 82.7%) agreed that they could rely on COVID-19 vaccines to stop serious infections and felt protected after getting vaccinated, respectively. Even so, respondents worried about unforeseen future effects of COVID-19 vaccines; the majority (81.7%) agreed that there might be problems with the vaccines that were currently unknown, although most of the vaccines appeared to be safe at the moment. Only 51.5% agreed that COVID-19 vaccines could cause unforeseen problems in children and 61.2% personally believed that there could be unknown long-term effects of the vaccine.
More than half of the respondents did not agree that vaccines make a large quantity of money for pharmaceutical companies but do not do much for regular people (63.7%); that authorities promote vaccination for financial gain, not for people’s health (81.4%); and that vaccination programmes are a big deception (89.6%). Moreover, the majority of respondents did not prefer natural immunity against COVID-19 infection, wherein 67.2% disagreed that natural immunity lasts longer than vaccination, 80% that natural exposure to viruses and germs gives the safest protection, and 82.9% that being exposed to diseases naturally is safer for the immune system than being exposed through vaccination (Table 6).

3.5. Public Confidence in Government and Willingness to Get Vaccinated

Slightly half of the respondents expressed their trust in the Malaysian government’s ability to manage the COVID-19 vaccination programme effectively (55.6%). However, more than half of the respondents believed that the Malaysian public health service effectively managed the COVID-19 vaccination program (72.3%). Regarding intention to get vaccinated, 99% of the respondents expressed their willingness to get vaccinated against COVID-19 (Table 7 and Table 8).

3.6. Ordinary Regression Analysis

Table 9 presents the results of regression models predicting four domains of negative attitudes towards the COVID-19 vaccine. Selected socio-demographic variables were controlled and entered in block one, while the main study variables were entered in block two. Overall, demographic variables accounted for a very small amount of variance in the four domains of negative attitudes towards COVID-19 vaccines (R2Mistrust = 7.2%; R2Worries = 4.3%; R2Concerns = 13.2%; R2Preference = 6.1%). More specifically, the results showed that age was positively associated with the four domains of negative attitudes towards COVID-19 vaccines ( β Mistrust = 0.23, p = 0.000; β Worries = 0.17, p = 0.000; β Concerns = 0.21, p = 0.000; β Preference = 0.22, p = 0.000). Compared to females, males were positively associated with only two domains—concerns about commercial profiteering ( β Concerns = 0.16, p = 0.000) and preference for natural immunity ( β Preference = 0.09, p = 0.015). All ethnic groups were worried about unforeseen future effects of COVID-19 vaccines ( β Malay = 0.57, p = 0.003; β Chinese = 0.51, p = 0.003; β Indian = 0.20, p = 0.006; β Bumiputera = 0.32, p = 0.006). Moreover, both Indians and Chinese had mistrust of vaccine benefits ( β Chinese = 0.53, p = 0.002; β Indian = 0.18, p = 0.016) and had concerns about commercial profiteering of COVID-19 vaccines ( β Chinese = 0.57, p = 0.001; βIndian = 0.51, p = 0.033). The results also revealed that income had a negative association with concerns about commercial profiteering of COVID-19 vaccines ( β = −0.09, p = 0.022) and preference for natural immunity ( β = −0.09, p = 0.042).
After controlling the demographic variables, the main predictors accounted for 8%–21.3% of variation for the four domains of negative attitudes towards COVID-19 vaccines (R2Mistrust = 15%; R2Worries = 8.7%; R2Concerns = 21.3%; R2Preference = 8.3%). As predicted, exposure to COVID-19 misinformation was positively associated with four domains of negative attitudes toward COVID-19 vaccines ( β Mistrust = 0.11, p = 0.000; β Worries = 0.13, p = 0.000; β Concerns = 0.10, p = 0.003; β Preference = 0.12, p = 0.001). Perceived risk had a negative relationship with mistrust of vaccine benefits ( β = −0.07, p = 0.039) but had a positive relationship with worries about unforeseen future effects of COVID-19 vaccines ( β = 0.10, p = 0.005). Moreover, people’s confidence in the government in managing the inoculation program was negatively associated with four domains of negative attitudes towards the COVID-19 vaccine ( β Mistrust = −0.26, p = 0.000; β Worries = −0.12, p = 0.000; β Concerns = −0.28, p = 0.000; β Preference = −0.09, p = 0.017).

4. Discussion

The results of our study indicate that misinformation on COVID-19 is quite common, with respondents reporting that they have seen/read at least one inaccurate claim on the vaccine. Specifically, the claim that respondents were most exposed to was that the COVID-19 vaccine causes serious side effects such as allergic reactions. Corroborating the finding above, a previous study in the country suggested that public vaccination uptake is significantly influenced by the low risk of severe side effects [39]. Interestingly, misperception of the side effects of COVID-19 vaccination also happened to be the top predictor of vaccine hesitancy in other countries such as Egypt [40], the United States [41,42], and several countries in Europe [43]. Another false claim that the respondents were highly exposed to was that the vaccine is unsafe because it was developed rapidly. The rapid development of the COVID-19 vaccine has raised many concerns about its safety and efficacy [44]. The urgency to provide the vaccine within a short period of time has also resulted in a major challenge for the government to ensure transparency in the process of vaccine development [45]. Not only in Malaysia, but this false claim about vaccine safety is also common among unvaccinated populations in the United States, Canada, Sweden, and Italy [46].
In terms of risk perception, respondents felt that COVID-19 was an important issue for them, and worries that they would be infected in the future were very high. Additionally, the majority of respondents perceived that they would likely be infected with COVID-19 and have previously felt at risk of being infected. Several studies have also linked public COVID-19 risk perception with the willingness or hesitancy to get vaccinated. For instance, a study by Al-Qerem and Jarab suggested perceived risk of infection as a predictor of vaccination intention among the Middle Eastern population [47].
In the United States, it was proven that the vaccinated population showed a higher level of COVID-19 risk perception compared to those who were unvaccinated [48]. Additionally, in Malaysia, worry about being infected was also found to be a predictor of parental intention to vaccinate their children [49]. Therefore, increasing public perceived risk can be an imperative move to improve the population’s vaccine intake, in which the government may produce strategic regulations and the media can play its role to shape public perception.
The present study has also revealed that public confidence in the Malaysian government’s ability to manage the vaccination programme was high. This finding corroborates a past study conducted in Malaysia, which explained how the public had high trust in the government’s ability to manage the COVID-19 crisis in the beginning of the pandemic [50]. Studies conducted around the world have shown that although public confidence and trust in government are important to the success of vaccination programmes [51], many governments struggle with this. For instance, with a long history of vaccine hesitancy, the COVID-19 vaccination rate in Nigeria was reported as being very low due to public distrust toward the government [52]. In addition, a review study synthesising the determinants of COVID-19 vaccine hesitancy in South Africa reported public distrust as one of the predictors of low vaccination intake in the country [53]. Only 1% of respondents in the present study indicated that they would not take the COVID-19 vaccine. Comparatively, this rate is much lower than in other Southeast Asian countries such as Singapore (9.9%) [54], Thailand (10.2%) [55], and Indonesia (13.2%) [56].
When the COVID-19 vaccine became available to the public, there was a mix of reactions. Those who were hesitant were reported to believe that the vaccine is dangerous and useless, and COVID-19 is harmless, while those who were willing to be vaccinated were influenced by the number of COVID-19 cases and deaths in their respective locations [57]. The results of this study show that Malaysians held low levels of mistrust toward vaccine benefits, with many feeling safe and protected after taking the vaccine. Even so, there was a high level of worry about the unforeseen future effects of the vaccine. The same concern was common among the public in Pakistan [58] and the United States [59]. This sentiment is common in new medical developments such as treatment and vaccinations. One of them is a false claim that the mRNA genetic material in several vaccines can possibly alter human DNA [60]. In addition, aside from safety and efficacy, the rapid development of COVID-19 vaccines has also raised concerns about long-term effects, with no exception among healthcare workers [2]. Earlier studies documented a small percentage of healthcare workers who were hesitant to receive the COVID-19 vaccine [61,62,63].
Studies in the West have identified concerns of commercial profiteering and a preference for natural immunity as prominent factors leading to vaccine hesitation. In the UK, where 16% of the public indicated a high-level mistrust of the COVID-19 vaccine, many people expressed extreme negative attitudes relating to commercial profiteering and a preference for natural immunity [5]. This was not reflected in the Malaysian public. The present study found that most did not agree that pharmaceutical companies made a profit off the vaccines as compared to regular members of the public. The majority also did not agree that natural immunity was better than vaccines in protecting individuals against COVID-19 infection.
In general, the results of this study indicate that higher exposure to misinformation led to higher levels of negative attitudes toward the COVID-19 vaccine. When the perceived risk of COVID-19 infection was high, mistrust of vaccine benefits was low but there were also higher worries about the future effects of the vaccine. In other words, the Malaysian public trust that the vaccine will keep them protected from COVID-19 but are wary of its long-term effects. Previously, it was reported that a high level of COVID-19 vaccine acceptance in the country was due to the high perceived benefits of the vaccine, although many are still in doubt about the risks after being vaccinated [64]. In this study, confidence in government was associated with lower negative attitudes toward the vaccine across all four domains (mistrust of vaccine benefits, worries about unforeseen future effects, commercial profiteering, and preference for natural immunity). These findings support previous studies on the moderating effect of trust in the success of national vaccination programmes. A global survey reported respondents from China, South Korea, and Singapore who had a higher level of trust toward the government were more likely to get vaccinated [65].
In the global context, patterns of vaccine acceptance have been shown to be higher in countries with higher levels of perceived risk [47] and higher trust and confidence in the government [65]. A study conducted in South Asia showed similarities between antecedents to COVID-19 vaccine acceptance between four different countries in the region [66]. Additionally, a systematic review found that vaccination acceptance rates were highest in Ecuador, Malaysia, Indonesia, and China (above 90%); the lowest (below 60%) in Kuwait, Jordan, Italy, Russia, Poland, Italy, and France [67]. This alludes to the idea that countries with similar characteristics may share similar sentiments toward COVID-19 vaccinations and similar antecedents to vaccine acceptance. An exploration of these broader contexts is recommended.

5. Limitations

This study utilised a convenience sampling procedure via personal and professional networks of the researchers, disseminated through online/short messaging services. This strategy may have introduced bias as some groups may have been excluded with this method of sampling. As a result, the sample does not accurately reflect the overall population. However, as the data collection was performed during a national lockdown, it was deemed the best way possible to collect data given the limitations. When compared to the national demographics, the gender distribution of the sample does not accurately reflect the current Malaysian population. The respondents of the study consisted of 69.2% women, while the current Malaysian population estimates that only 49% of the population is female. In terms of racial distribution, the study had a similar percentage reflecting the two main races in the country; however, only 2.6% of respondents were Indian, while the current national statistics estimates 6.8% of the country’s population is Indian. In terms of the income distribution, 53.7% of respondents belonged to the below 40% income bracket, only 27.1% of respondents were in the middle 40% income bracket, and 19.2% of respondents came from the top 20% income bracket. This variation affects the representativeness of findings to the overall population.
Another limitation that any self-administered survey has is a social desirability bias among respondents. Respondents tend to answer questions on the basis of what they think will make them look good or what they perceive is the answer that other people expect from them. However, this study has tried to reduce this bias by assuring anonymised data collection and utilising online platforms.

6. Conclusions

This study explored factors that influence an individual’s negative attitudes toward vaccination. Findings showed that higher exposure to misinformation and perceived risk of COVID-19 infection led to higher negative attitudes toward the COVID-19 vaccine. This study also found that the public’s confidence in the government was high and associated with lower negative attitudes toward the vaccine across all four domains (mistrust on vaccine benefits, worries about unforeseen future effects, commercial profiteering, and preference for natural immunity).

Author Contributions

Conceptualisation, E.M., A.A.A., M.R.H., J.S.T., S.H.A. and S.Z.M.A.; Data curation, S.Z.M.A.; Formal analysis, J.S.T.; Funding acquisition, E.M.; Investigation, E.M., A.A.A., M.R.H., J.S.T., S.H.A. and S.Z.M.A.; Methodology, E.M., A.A.A., M.R.H., J.S.T., S.H.A. and S.Z.M.A.; Project administration, E.M. and A.A.A.; Resources, E.M. and A.A.A.; Software, J.S.T.; Supervision, A.A.A. and E.M.; Validation, A.A.A. and E.M.; Visualisation, J.S.T.; Writing—original draft, E.M., A.A.A., M.R.H., J.S.T., S.H.A., S.Z.M.A. and A.M.T.S.; Writing—review and editing, E.M., A.A.A. and A.M.T.S. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by a grant from Universiti Kebangsaan Malaysia (grant code: DPK-2021-008) and in collaboration with UNICEF Malaysia (grant code: SK-2020-030). The funder had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.

Institutional Review Board Statement

The study was reviewed and approved by the Ethics Committee of Universiti Kebangsaan Malaysia, reference number: UKM PPI/111/8/JEP-2021-286.

Informed Consent Statement

Informed consent was obtained from all respondents of this study. Respondents were informed of the purpose of the study, were told of its risks and benefits, and were assured of anonymity. Those who consented to willingly participate in the survey indicated their agreement by ticking a box on the online survey form before being directed to complete the self-administered questionnaire.

Data Availability Statement

The data presented in this study are available on request from the corresponding author. The data are not publicly available due to ethical considerations.

Acknowledgments

We would like to express our appreciation to Shamsiah Abd Kadir and UNICEF Malaysia for their support in this study.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Ministry of Health Malaysia. Clinical Guidelines on COVID-19 Vaccination in Malaysia, 4th ed. Available online: https://covid-19.moh.gov.my/garis-panduan/garis-panduan-kkm/ANNEX_48_CLINICAL_GUIDELINES_FOR_COVID_IN_MALAYSIA_4th_EDITION_19102021_FINALE.pdf (accessed on 1 October 2022).
  2. Dror, A.A.; Eisenbach, N.; Taiber, S.; Morozov, N.G.; Mizrachi, M.; Zigron, A.; Srouji, S.; Sela, E. Vaccine hesitancy: The next challenge in the fight against COVID-19. Eur. J. Epidemiol. 2020, 35, 775–779. [Google Scholar] [CrossRef] [PubMed]
  3. Danabal, K.G.M.; Magesh, S.S.; Saravanan, S.; Gopichandran, V. Attitude towards COVID-19 vaccines and vaccine hesitancy in urban and rural communities in Tamil Nadu, India—A community based survey. BMC Health Serv. Res. 2021, 21, 994. [Google Scholar] [CrossRef] [PubMed]
  4. Cordina, M.; Lauri, M.A.; Lauri, J. Attitudes towards COVID-19 vaccination, vaccine hesitancy and intention to take the vaccine. Pharm. Pract. 2021, 19, 2317. [Google Scholar] [CrossRef] [PubMed]
  5. Paul, E.; Steptoe, A.; Fancourt, D. Attitudes towards vaccines and intention to vaccinate against COVID-19: Implications for public health communications. Lancet Reg. Health Eur. 2021, 1, 100012. [Google Scholar] [CrossRef]
  6. Iguacel, I.; Maldonado, A.L.; Ruiz-Cabello, A.L.; Samatán, E.; Alarcón, J.; Orte, M.; Mateos, S.S.; Martínez-Jarreta, B. Attitudes of Healthcare Professionals and General Population Toward Vaccines and the Intention to Be Vaccinated Against COVID-19 in Spain. Front. Public Health 2021, 9, 739003. [Google Scholar] [CrossRef]
  7. Tahir, M.J.; Saqlain, M.; Tariq, W.; Waheed, S.; Tan, S.H.S.; Nasir, S.I.; Ullah, I.; Ahmed, A. Population preferences and attitudes towards COVID-19 vaccination: A cross-sectional study from Pakistan. BMC Public Health 2021, 21, 1759. [Google Scholar] [CrossRef]
  8. Suarez-Lledo, V.; Alvarez-Galvez, J. Prevalence of health misinformation on social media: Systematic review. J. Med. Internet Res. 2021, 23, e17187. [Google Scholar] [CrossRef]
  9. Panahi, S.; Ghalavand, H.; Sedghi, S. Opportunities and challenges of social media for health knowledge management: A narrative review. J. Educ. Health Promot. 2020, 9, 144. [Google Scholar] [CrossRef]
  10. Kim, H.K.; Tandoc, E.C.J. Consequences of online misinformation on COVID-19: Two potential pathways and disparity by eHealth literacy. Front. Psychol. 2022, 13, 783909. [Google Scholar] [CrossRef]
  11. Barua, Z.; Barua, S.; Aktar, S.; Kabir, N.; Li, M. Effects of misinformation on COVID-19 individual responses and recommendations for resilience of disastrous consequences of misinformation. Prog. Disaster Sci. 2020, 8, 100119. [Google Scholar] [CrossRef]
  12. Nelson, T.; Kagan, N.; Critchlow, C.; Hillard, A.; Hsu, A. The danger of misinformation in the COVID-19 crisis. Mo. Med. 2020, 117, 510–512. [Google Scholar] [PubMed]
  13. Organisation for Economic Co-operation and Development, OECD. Transparency, Communication and Trust: The Role of Public Communication in Responding to the Wave of Disinformation about the New Coronavirus. Tackling Coronavirus (COVID-19). 2020, pp. 1–12. Available online: https://www-oecd-org.proxy.library.uu.nl/coronavirus/policy-responses/transparency-communication-and-trust-bef7ad6e/#figure-d1e97%0Ahttps://read.oecd-ilibrary.org/view/?ref=135_135220-cvba4lq3ru&title=Transparency-communication-and-trust-The-role-of-publi (accessed on 1 October 2022).
  14. Han, Q.; Zheng, B.; Cristea, M.; Agostini, M.; Bélanger, J.J.; Gützkow, B.; Kreienkamp, J.; Leander, N.P. PsyCorona Collaboration. Trust in government regarding COVID-19 and its associations with preventive health behaviour and prosocial behaviour during the pandemic: A cross-sectional and longitudinal study. Psychol. Med. 2021, 1–11. [Google Scholar] [CrossRef] [PubMed]
  15. Schmid, P.; Rauber, D.; Betsch, C.; Lidolt, G.; Denker, M.-L. Barriers of Influenza Vaccination Intention and Behavior—A Systematic Review of Influenza Vaccine Hesitancy, 2005–2016. PLoS ONE 2017, 12, e0170550. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  16. Palamenghi, L.; Barello, S.; Boccia, S.; Graffigna, G. Mistrust in biomedical research and vaccine hesitancy: The forefront challenge in the battle against COVID-19 in Italy. Eur. J. Epidemiol. 2020, 35, 785–788. [Google Scholar] [CrossRef]
  17. Simione, L.; Vagni, M.; Gnagnarella, C.; Bersani, G.; Pajardi, D. Mistrust and beliefs in conspiracy theories differently mediate the effects of psychological factors on propensity for COVID-19 vaccine. Front. Psychol. 2021, 12, 683684. [Google Scholar] [CrossRef]
  18. Rani, M.D.M.; Mohamed, N.A.; Solehan, H.M.; Ithnin, M.; Ariffien, A.R.; Isahak, I. Assessment of acceptability of the COVID-19 vaccine based on the health belief model among Malaysians-A qualitative approach. PLoS ONE 2022, 17, e0269059. [Google Scholar] [CrossRef]
  19. Du, M.; Tao, L.; Liu, J. The association between risk perception and COVID-19 vaccine hesitancy for children among reproductive women in China: An online survey. Front. Med. 2021, 8, 741298. [Google Scholar] [CrossRef]
  20. Bhuiya, T.; Iii, R.K.; Conte, M.A.; Cervia, J.S. Predictors of misperceptions, risk perceptions, and personal risk perceptions about COVID-19 by country, education and income. J. Investig. Med. 2021, 69, 1473–1478. [Google Scholar] [CrossRef]
  21. Solís Arce, J.S.; Warren, S.S.; Meriggi, N.F.; Scacco, A.; McMurry, N.; Voors, M.; Syunyaev, G.; Malik, A.A.; Aboutajdine, S.; Adeojo, O.; et al. COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries. Nat. Med. 2021, 27, 1385–1394. [Google Scholar] [CrossRef]
  22. Wagner, A.L.; Masters, N.B.; Domek, G.J.; Mathew, J.L.; Sun, X.; Asturias, E.J.; Ren, J.; Huang, Z.; Contreras-Roldan, I.L.; Gebremeskel, B.; et al. Comparisons of vaccine hesitancy across five low- and middle-income countries. Vaccines 2019, 7, 155. [Google Scholar] [CrossRef]
  23. Pek, C.K.; Choy, K.Y.; Toh, K.K.; Foo, F.E.; Cham, T.H. Dataset of vaccination and confidence in the Malaysian government during COVID-19 pandemic. Data Brief 2022, 42, 108148. [Google Scholar] [CrossRef] [PubMed]
  24. Jafar, A.; Dambul, R.; Dollah, R.; Sakke, N.; Mapa, M.T.; Joko, E.P. COVID-19 vaccine hesitancy in Malaysia: Exploring factors and identifying highly vulnerable groups. PLoS ONE 2022, 17, e0270868. [Google Scholar] [CrossRef] [PubMed]
  25. Ruhi, S.; Nabilah, P.; Attalla, S.M.; Treki, M.; Khan, J.; Ishaka, A.; Baber, S.; Kaleemullah, M.; Hasan, S. Understanding the negative public perception on vaccination in west coast and east coast peninsular Malaysia. Malays. J. Med. Health Sci. 2021, 17, 77–82. [Google Scholar]
  26. Napolitano, F.; D’Alessandro, A.; Angelillo, I.F. Investigating Italian parents’ vaccine hesitancy: A cross-sectional survey. Hum. Vaccines Immunother. 2018, 14, 1558–1565. [Google Scholar] [CrossRef] [Green Version]
  27. Phillips, R.; Gillespie, D.; Hallingberg, B.; Evans, J.; Taiyari, K.; Torrens-Burton, A.; Cannings-John, R.; Williams, D.; Sheils, E.; Ashfield-Watt, P.; et al. Perceived threat of COVID-19, attitudes towards vaccination, and vaccine hesitancy: A prospective longitudinal study in the UK. Br. J. Health Psychol. 2022, 27, 1354–1381. [Google Scholar] [CrossRef]
  28. Conroy, R. Sample size: A rough guide. Ethics (Medical Research) Committee. 2015. Available online: http://www.beaumontethics.ie/docs/application/samplesizecalculation.pdf (accessed on 1 October 2022).
  29. Israel, G.D. Determining Sample Size; Report No.: Fact Sheet PEOD-6; University of Florida: Gainesville, FL, USA, 1992. [Google Scholar]
  30. Malaysian Communications and Multimedia Commission. Internet Users Survey 2018: Statistical Brief Number Twenty-Three. Cyberjaya: MCMC. 2018. Available online: https://www.mcmc.gov.my/skmmgovmy/media/General/pdf/Internet-Users-Survey-2018.pdf (accessed on 10 May 2020).
  31. Brislin, R.W. Back-translation for cross-cultural research. J. Cross-Cult. Psychol. 1970, 3, 185–216. [Google Scholar] [CrossRef]
  32. Kim, H.K.; Ahn, J.; Atkinson, L.; Kahlor, L.A. Effects of COVID-19 misinformation on information seeking, avoidance, and processing: A multicountry comparative study. Sci. Commun. 2020, 42, 586–615. [Google Scholar] [CrossRef]
  33. Oh, S.-H.; Paek, H.-J.; Hove, T. Cognitive and emotional dimensions of perceived risk characteristics, genre-specific media effects, and risk perceptions: The case of H1N1 influenza in South Korea. Asian J. Commun. 2015, 25, 14–32. [Google Scholar] [CrossRef]
  34. Han, G.; Zhang, J.; Chu, K.; Shen, G. Self-other differences in H1N1 flu risk perception in a global context: A comparative study between the United States and China. Health Commun. 2014, 29, 109–123. [Google Scholar] [CrossRef]
  35. Lee, J.; Kim, J.W.; Chock, T.M. From risk butterflies to citizens engaged in risk prevention in the zika virus crisis: Focusing on personal, societal and global risk perceptions. J. Health Commun. 2020, 25, 671–680. [Google Scholar] [CrossRef]
  36. Martin, L.R.; Petrie, K.J. Understanding the dimensions of anti-vaccination attitudes: The vaccination attitudes examination (VAX) Scale. Ann. Behav. Med. 2017, 51, 652–660. [Google Scholar] [CrossRef] [PubMed]
  37. Malik, A.A.; McFadden, S.M.; Elharake, J.; Omer, S.B. Determinants of COVID-19 vaccine acceptance in the US. eClinicalMedicine 2020, 26, 100495. [Google Scholar] [CrossRef] [PubMed]
  38. van Griethuijsen, R.A.; van Eijck, M.W.; Haste, H.; den Brok, P.J.; Skinner, N.C.; Mansour, N.; Gencer, A.S.; BouJaoude, S. Global patterns in students’ views of science and interest in science. Res. Sci. Educ. 2015, 45, 581–603. [Google Scholar] [CrossRef]
  39. Teh, H.S.; Woon, Y.L.; Leong, C.T.; Hing, N.Y.L.; Mien, T.Y.S.; Roope, L.S.; Clarke, P.M.; Lim, L.-L.; Buckell, J. Malaysian public preferences and decision making for COVID-19 vaccination: A discrete choice experiment. Lancet Reg. Health West. Pac. 2022, 27, 100534. [Google Scholar] [CrossRef]
  40. Saied, S.M.; Saied, E.M.; Kabbash, I.A.; Abdo, S.A.E. Vaccine hesitancy: Beliefs and barriers associated with COVID-19 vaccination among Egyptian medical students. J. Med. Virol. 2021, 93, 4280–4291. [Google Scholar] [CrossRef]
  41. Kreps, S.E.; Goldfarb, J.L.; Brownstein, J.S.; Kriner, D.L. The relationship between US adults’ misconceptions about COVID-19 vaccines and vaccination preferences. Vaccines 2021, 9, 901. [Google Scholar] [CrossRef]
  42. Neely, S.R.; Eldredge, C.; Ersing, R.; Remington, C. Vaccine hesitancy and exposure to misinformation: A survey analysis. J. Gen. Intern. Med. 2022, 37, 179–187. [Google Scholar] [CrossRef]
  43. Neumann-Böhme, S.; Varghese, N.E.; Sabat, I.; Barros, P.P.; Brouwer, W.; Van Exel, J.; Schreyögg, J.; Stargardt, T. Once we have it, will we use it? A European survey on willingness to be vaccinated against COVID-19. Eur. J. Health Econ. 2020, 21, 977–982. [Google Scholar] [CrossRef]
  44. Fadda, M.; Albanese, E.; Suggs, L.S. When a COVID-19 vaccine is ready, will we all be ready for it? Int. J. Public Health 2020, 65, 711–712. [Google Scholar] [CrossRef]
  45. Kashte, S.; Gulbake, A.; El-Amin, S.F., III; Gupta, A. COVID-19 vaccines: Rapid development, implications, challenges and future prospects. Hum. Cell 2021, 34, 711–733. [Google Scholar] [CrossRef]
  46. Piltch-Loeb, R.; Harriman, N.W.; Healey, J.; Bonetti, M.; Toffolutti, V.; Testa, M.A.; Su, M.; Savoia, E. COVID-19 vaccine concerns about safety, effectiveness, and policies in the United States, Canada, Sweden, and Italy among unvaccinated individuals. Vaccines 2021, 9, 1138. [Google Scholar] [CrossRef] [PubMed]
  47. Al-Qerem, W.A.; Jarab, A.S. COVID-19 vaccination acceptance and its associated factors among a middle eastern population. Front. Public Health 2021, 9, 632914. [Google Scholar] [CrossRef]
  48. Tu, P.; Kotarba, M.; Bier, B.; Clark, R.; Lin, C. Internal and external motivations and risk perception toward COVID-19 vaccination in adolescents in the U.S. Vaccines 2022, 10, 697. [Google Scholar] [CrossRef] [PubMed]
  49. Bono, S.A.; Siau, C.S.; Chen, W.S.; Low, W.Y.; Villela, E.F.D.M.; Pengpid, S.; Hasan, M.T.; Sessou, P.; Ditekemena, J.D.; Amodan, B.O.; et al. Adults’ acceptance of COVID-19 vaccine for children in selected lower- and middle-income countries. Vaccines 2022, 10, 11. [Google Scholar] [CrossRef] [PubMed]
  50. Azlan, A.A.; Hamzah, M.R.; Sern, T.J.; Ayub, S.H.; Mohamad, E. Public knowledge, attitudes and practices towards COVID-19: A cross-sectional study in Malaysia. PLoS ONE 2020, 15, e0233668. [Google Scholar] [CrossRef]
  51. Lqbal MT, B.M.; Imran SA, M.; Tye, G.J.; Zaman, W.K.; Nordin, F. COVID-19 vaccination effectiveness: A review in early vaccine adopters in Asian Countries. Eur. Rev. Med. Pharmacol. Sci. 2022, 26, 4902–4925. [Google Scholar]
  52. Sato, R. COVID-19 vaccine hesitancy and trust in government in Nigeria. Vaccines 2022, 10, 1008. [Google Scholar] [CrossRef]
  53. Cooper, S.; van Rooyen, H.; Wiysonge, C.S. COVID-19 vaccine hesitancy in South Africa: How can we maximize uptake of COVID-19 vaccines? Expert Rev. Vaccines 2021, 20, 921–933. [Google Scholar] [CrossRef]
  54. Griva, K.; Tan, K.Y.K.; Chan, F.H.F.; Periakaruppan, R.; Ong, B.W.L.; Soh, A.S.E.; Chen, M.I. Evaluating rates and determinants of COVID-19 vaccine hesitancy for adults and children in the Singapore population: Strengthening our community’s resilience against threats from emerging infections (SOCRATEs) cohort. Vaccines 2021, 9, 1415. [Google Scholar] [CrossRef]
  55. Mueangpoon, K.; Inchan, C.; Kaewmuneechoke, P.; Rattana, P.; Budsratid, S.; Japakiya, S.; Ngamchaliew, P.; Vichitkunakorn, P. Self-reported COVID-19 vaccine hesitancy and willingness to pay: A cross-sectional survey in Thailand. Vaccines 2022, 10, 627. [Google Scholar] [CrossRef]
  56. Yanto, T.A.; Octavius, G.S.; Heriyanto, R.S.; Ienawi, C.; Nisa, H.; Pasai, H.E. Psychological factors affecting COVID-19 vaccine acceptance in Indonesia. Egypt. J. Neurol. Psychiatry Neurosurg. 2021, 57, 177. [Google Scholar] [CrossRef] [PubMed]
  57. Kukreti, S.; Rifai, A.; Padmalatha, S.; Lin, C.Y.; Yu, T.; Ko, W.C.; Chen, P.-L.; Strong, C.; Ko, N.-Y. Willingness to obtain COVID-19 vaccination in general population: A systematic review and meta-analysis. J. Glob. Health 2022, 12, 05006. [Google Scholar] [CrossRef]
  58. Khattak, S.; Idrees, M.; Iqbal, H.I.; Khan, M.; Assad, N.; Khan, M.N.; Yousaf, M.T.; Farooq, M.; Yang, C.-Y.; Wu, D.-D.; et al. Assessment of attitudes and intentions towards COVID-19 vaccines and associated factors among general populations of Pakistan: A cross-sectional study. Vaccines 2022, 10, 1583. [Google Scholar] [CrossRef]
  59. Callaghan, T.; Moghtaderi, A.; Lueck, J.A.; Hotez, P.; Strych, U.; Dor, A.; Fowler, E.F.; Motta, M. Correlates and disparities of intention to vaccinate against COVID-19. Soc. Sci. Med. 2021, 272, 113638. [Google Scholar] [CrossRef]
  60. Reuters. False Claim: A COVID-19 Vaccine will Genetically Modify Humans. 2020. Available online: https://www.reuters.com/article/uk-factcheck-covid-19-vaccine-modify-idUSKBN22U2BZ (accessed on 13 December 2020).
  61. Gagneux-Brunon, A.; Detoc, M.; Bruel, S.; Tardy, B.; Rozaire, O.; Frappe, P.; Botelho-Nevers, E. Intention to get vaccinations against COVID-19 in French healthcare workers during the first pandemic wave: A cross-sectional survey. J. Hosp. Infect. 2021, 108, 168–173. [Google Scholar] [CrossRef]
  62. Shekhar, R.; Sheikh, A.; Upadhyay, S.; Singh, M.; Kottewar, S.; Mir, H.; Barrett, E.; Pal, S. COVID-19 Vaccine Acceptance among Health Care Workers in the United States. Vaccines 2021, 9, 119. [Google Scholar] [CrossRef]
  63. Nailul Muna, A.M.; Khalid, K.; Siti Noriani, A.W.; Irma Liyana, M.; Siti Zulaiha, C.H.; Mohamad Zamri, K.; Othman, W. COVID-19 vaccine hesitancy: Mobile education initiatives to improve vaccination uptake among healthcare workers. Med. Health 2022, 17, 260–266. [Google Scholar]
  64. Sri, A.H. Public awareness, knowledge, and attitude towards conventional and modern biotechnology based vaccines in Malaysia. J. Pengaj. Umum Asia Tenggara 2021, 22, 198–214. [Google Scholar]
  65. Lazarus, J.V.; Ratzan, S.C.; Palayew, A.; Gostin, L.O.; Larson, H.J.; Rabin, K.; Kimball, S.; El-Mohandes, A. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. 2021, 27, 225–228. [Google Scholar] [CrossRef]
  66. Hawlader, M.D.H.; Rahman, M.L.; Nazir, A.; Ara, T.; Haque, M.M.A.; Saha, S.; Barsha, S.Y.; Hossian, M.; Matin, K.F.; Siddiquea, S.R.; et al. COVID-19 vaccine acceptance in South Asia: A multi-country study. Int. J. Infect. Dis. 2021, 114, 1–10. [Google Scholar] [CrossRef]
  67. Sallam, M. COVID-19 vaccine hesitancy worldwide: A concise systematic review of vaccine acceptance rates. Vaccines 2021, 9, 160. [Google Scholar] [CrossRef] [PubMed]
Table 1. Socio-demographic profiles (n = 775). a Mean ± standard deviation (range).
Table 1. Socio-demographic profiles (n = 775). a Mean ± standard deviation (range).
Total
n%
Socio-demographic:
Gender
Female53669.2
Male23930.8
Age33.71 ± 10.71 (18–75) a
Ethnicity
Malay52367.5
Chinese16721.5
Indian202.6
Bumiputera (Sabah/Sarawak)597.6
Others60.8
Locality
Urban50364.9
Rural27235.1
State
Johor607.7
Kedah415.3
Kelantan293.7
Melaka192.5
Negeri Sembilan445.7
Pahang314.0
Perak435.5
Perlis60.8
Pulau Pinang222.8
Terengganu273.5
Sabah303.9
Sarawak415.3
Selangor28136.3
Federal Territory of Kuala Lumpur8711.2
Federal Territory of Putrajaya10.1
Federal Territory of Labuan131.7
Employment status
Government employee14719.0
Private employee36447.0
Self-employed (registered)354.5
Self-employed (not registered)293.7
Unpaid family worker40.5
Not employed19625.3
Income
Under MYR 4360 per month (including no income)41653.7
MYR 4361–9620 per month21027.1
Above MYR 9621 per month14919.2
Health status
Very bad101.3
Bad141.8
Average9612.4
Good38149.2
Very good27435.4
Health problem
Yes, more than one disease395.0
Yes, only one disease10613.7
No diseases63081.3
Table 2. Primary sources of COVID-19 information.
Table 2. Primary sources of COVID-19 information.
Source of InformationFrequencyPercentage
Government organisations25532.9
Newspaper or online newspapers23129.8
Doctor or healthcare provider10813.9
Brochures, pamphlets, etc.628.0
Other486.2
Friends/co-workers344.4
Family334.3
Alternative medicine practitioner40.5
Table 3. Media platforms used for COVID-19 vaccine news.
Table 3. Media platforms used for COVID-19 vaccine news.
MediaPercentage
YesNo
Online news portal69.031.0
Facebook68.032.0
Television64.435.6
WhatsApp51.548.5
Instagram39.560.5
Telegram32.567.5
Twitter31.668.4
Radio29.470.6
YouTube25.874.2
Table 4. Exposure to misinformation on COVID-19 vaccination.
Table 4. Exposure to misinformation on COVID-19 vaccination.
Total
n%
COVID-19 vaccines affect human DNA.
Not at all46459.9
Rarely18123.4
Occasionally8811.4
Very frequently425.4
COVID-19 vaccines contain pig fat.
Not at all47260.9
Rarely18123.4
Occasionally7810.1
Very frequently445.7
A nurse fainted after she received the COVID-19 vaccine.
Not at all32642.1
Rarely30539.4
Occasionally10613.7
Very frequently384.9
COVID-19 vaccines contain live viruses that can make people sick with COVID-19.
Not at all41353.3
Rarely21327.5
Occasionally10713.8
Very frequently425.4
Those who have recovered from COVID-19 do not need to get vaccinated.
Not at all45859.1
Rarely17122.1
Occasionally9712.5
Very frequently496.3
Vaccines for COVID-19 have a microchip that can track the location of the patient.
Not at all46560.0
Rarely12916.6
Occasionally7910.2
Very frequently10213.2
The COVID-19 vaccines are not safe because they were developed rapidly.
Not at all29337.8
Rarely19825.5
Occasionally13517.4
Very frequently14919.2
The COVID-19 vaccine causes serious side effects like allergic reactions.
Not at all13617.5
Rarely29638.2
Occasionally18523.9
Very frequently15820.4
The COVID-19 vaccine can cause infertility in women.
Not at all49664.0
Rarely20226.1
Occasionally557.1
Very frequently222.8
Once you receive the COVID-19 vaccine, you will not have to wear a mask or practice social-distancing.
Not at all44657.5
Rarely15319.7
Occasionally8410.8
Very frequently9211.9
Table 5. Risk perception about COVID-19.
Table 5. Risk perception about COVID-19.
Total
n%
The problem of the COVID-19 pandemic is important to me.
Not at all60.8
Slightly40.5
Moderately182.3
Quite a bit658.4
Very much23730.6
Completely44557.4
I am worried that I may be infected with COVID-19 in the future.
Not at all111.4
Slightly162.1
Moderately374.8
Quite a bit9111.7
Very much16721.5
Completely45358.5
It is likely that I will be infected with COVID-19.
Not at all405.2
Slightly9812.6
Moderately14118.2
Quite a bit19625.3
Very much14018.1
Completely16020.6
I have felt at risk of COVID-19 infection.
Not at all12015.5
Slightly9211.9
Moderately10613.7
Quite a bit15019.4
Very much15920.5
Completely14819.1
Table 6. Four domains of negative attitudes towards the vaccination programme. a Items were reverse coded.
Table 6. Four domains of negative attitudes towards the vaccination programme. a Items were reverse coded.
Total
n%
Mistrust of vaccine benefits:
I feel safe after being vaccinated. a
Strongly disagree273.5
Disagree263.4
Slightly disagree8511.0
Slightly agree18624.0
Agree22328.8
Strongly agree22829.4
I can rely on vaccines to stop serious infectious diseases. a
Strongly disagree476.1
Disagree536.8
Slightly disagree11314.6
Slightly agree20726.7
Agree18223.5
Strongly agree17322.3
I feel protected after getting vaccinated. a
Strongly disagree222.8
Disagree283.6
Slightly disagree8410.8
Slightly agree20025.8
Agree22929.5
Strongly agree21227.4
Worries about unforeseen future effects:
Although most vaccines appear to be safe, there may be problems that we have not yet discovered.
Strongly disagree121.5
Disagree253.2
Slightly disagree10513.5
Slightly agree21427.6
Agree20526.5
Strongly agree21427.6
Vaccines can cause unforeseen problems in children.
Strongly disagree648.3
Disagree10613.7
Slightly disagree20626.6
Slightly agree19525.2
Agree12215.7
Strongly agree8210.6
I worry about the unknown effects of vaccines in the future.
Strongly disagree597.6
Disagree10213.2
Slightly disagree14018.1
Slightly agree21627.9
Agree13016.8
Strongly agree12816.5
Concerns about commercial profiteering:
Vaccines make a lot of money for pharmaceutical companies, but do not do much for regular people.
Strongly disagree16020.6
Disagree14118.2
Slightly disagree19324.9
Slightly agree14318.5
Agree678.6
Strongly agree719.2
Authorities promote vaccination for financial gain, not for people’s health.
Strongly disagree33543.2
Disagree17722.8
Slightly disagree11915.4
Slightly agree9211.9
Agree283.6
Strongly agree243.1
Vaccination programs are a big deception.
Strongly disagree45759.0
Disagree13116.9
Slightly disagree10613.7
Slightly agree638.1
Agree101.3
Strongly agree81.0
Preference for natural immunity:
Natural immunity lasts longer than vaccination.
Strongly disagree17322.3
Disagree14919.2
Slightly disagree19925.7
Slightly agree12816.5
Agree698.9
Strongly agree577.4
Natural exposure to viruses and germs gives the safest protection.
Strongly disagree27235.1
Disagree16521.3
Slightly disagree18323.6
Slightly agree9512.3
Agree384.9
Strongly agree222.8
Being exposed to diseases naturally is safer for the immune system than being exposed through vaccination.
Strongly disagree27936.0
Disagree17322.3
Slightly disagree19124.6
Slightly agree9312.0
Agree243.1
Strongly agree151.9
Table 7. Public confidence in the government. a Number for each item may not add up to a total number of study population due to missing values.
Table 7. Public confidence in the government. a Number for each item may not add up to a total number of study population due to missing values.
Total
n%
I am confident in the Malaysian government’s ability to effectively manage the COVID-19 vaccination program. a
1 (No confidence)7710.1
210113.2
316221.1
416821.9
514619.1
6 (Very high confidence)11214.6
I am confident in the ability of the Malaysian public health service to effectively manage the COVID-19 vaccination program. a
1 (No confidence)324.2
2618.0
311915.5
418123.6
520326.5
6 (Very high confidence)17022.2
Table 8. Willingness to get vaccinated. a Number for each item may not add up to the total number of study respondents due to missing values.
Table 8. Willingness to get vaccinated. a Number for each item may not add up to the total number of study respondents due to missing values.
Total
n%
If a COVID-19 vaccine is recommended for you, would you take it? a
No81.0
Yes75699.0
Table 9. Results of regression models predicting four domains of negative attitudes towards the COVID-19 vaccine.
Table 9. Results of regression models predicting four domains of negative attitudes towards the COVID-19 vaccine.
VariablesMistrust of
Vaccine Benefits
Worries about Unforeseen Future EffectsConcerns about
Commercial Profiteering
Preference for Natural Immunity
Block 1Block 2Block 1Block 2Block 1Block 2Block 1Block 2
t t t t t t t t
Male (vs. female)0.0020.059−0.02−0.440.061.680.051.220.164.52 ***0.144.09 ***0.092.44 *0.082.17 *
Age0.235.38 ***0.245.87 ***0.173.84 ***0.194.45 ***0.215.16 ***0.235.92 ***0.225.16 ***0.235.39 ***
Ethnicity (vs. other)
Malay0.371.940.372.02 *0.572.98 **0.562.95 **0.311.700.311.770.060.320.050.26
Chinese0.533.13 **0.472.87 **0.512.95 **0.492.90 **0.533.23 ***0.473.00 **0.181.050.160.93
Indian0.182.40 *0.172.42 *0.202.75 **0.223.06 **0.152.14 *0.152.29 *0.040.560.050.63
Bumiputera Sabah/Sarawak0.211.840.242.17 *0.322.78 **0.332.93 **0.121.060.141.380.050.410.060.49
Income−0.04−0.95−0.06−1.41−0.03−0.79−0.04−1.07−0.09−2.29 *−0.11−2.91 **−0.09−2.04 *−0.09−2.22 *
Rural (vs. urban)0.061.640.082.18 *0.010.120.020.48−0.01−0.210.020.430.041.010.051.18
Employment (vs. private)
Government−0.06−1.55−0.05−1.35−0.01−0.19−0.01−0.210.0010.030.010.330.020.490.020.48
Self-employed (registered)0.010.39−0.004−0.110.030.870.020.550.010.16−0.01−0.39−0.02−0.53−0.03−0.79
Self-employed (non-registered)0.010.20−0.001−0.02−0.05−1.24−0.05−1.43−0.03−0.79−0.04−1.04−0.03−0.74−0.03−0.91
Unpaid−0.03−0.03−0.03−0.81−0.04−1.13−0.05−1.36−0.02−0.53−0.02−0.64−0.01−0.34−0.02−0.44
Not employed0.061.570.041.190.010.180.010.290.010.17−0.01−0.180.00−0.01−0.003−0.07
COVID-19 vaccine misinformation exposure--0.113.31 **--0.133.57 ***--0.102.96 **--0.123.21 ***
Perceived risk--−0.070.04 *--0.102.81 **--0.0030.08--−0.003−0.08
Confidence in government--−0.26−7.07 ***--−0.12−3.23 ***--−0.28−7.98 ***--−0.09−2.40 *
Adj R2 = 0.132
ΔR2 = 0.078
F(16, 749) = 8.26 ***
Adj R2 = 0.068
ΔR2 = 0.044
F(16, 749) = 4.48 ***
Adj R2 = 0.197
ΔR2 = 0.082
F(16, 749) = 12.70 ***
Adj R2 = 0.063
ΔR2 = 0.022
F(16, 749) = 4.24 ***
* p < 0.05. ** p < 0.01. *** p < 0.001.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Mohamad, E.; Tham, J.S.; Mohd Ajis, S.Z.; Hamzah, M.R.; Ayub, S.H.; Tri Sakti, A.M.; Azlan, A.A. Exposure to Misinformation, Risk Perception, and Confidence towards the Government as Factors Influencing Negative Attitudes towards COVID-19 Vaccination in Malaysia. Int. J. Environ. Res. Public Health 2022, 19, 14623. https://doi.org/10.3390/ijerph192214623

AMA Style

Mohamad E, Tham JS, Mohd Ajis SZ, Hamzah MR, Ayub SH, Tri Sakti AM, Azlan AA. Exposure to Misinformation, Risk Perception, and Confidence towards the Government as Factors Influencing Negative Attitudes towards COVID-19 Vaccination in Malaysia. International Journal of Environmental Research and Public Health. 2022; 19(22):14623. https://doi.org/10.3390/ijerph192214623

Chicago/Turabian Style

Mohamad, Emma, Jen Sern Tham, Siti Zaiton Mohd Ajis, Mohammad Rezal Hamzah, Suffian Hadi Ayub, Andi Muhammad Tri Sakti, and Arina Anis Azlan. 2022. "Exposure to Misinformation, Risk Perception, and Confidence towards the Government as Factors Influencing Negative Attitudes towards COVID-19 Vaccination in Malaysia" International Journal of Environmental Research and Public Health 19, no. 22: 14623. https://doi.org/10.3390/ijerph192214623

APA Style

Mohamad, E., Tham, J. S., Mohd Ajis, S. Z., Hamzah, M. R., Ayub, S. H., Tri Sakti, A. M., & Azlan, A. A. (2022). Exposure to Misinformation, Risk Perception, and Confidence towards the Government as Factors Influencing Negative Attitudes towards COVID-19 Vaccination in Malaysia. International Journal of Environmental Research and Public Health, 19(22), 14623. https://doi.org/10.3390/ijerph192214623

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop